Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).

Katherin Zambrano-VeraArmando SardiFelipe Lopez-RamirezMichelle SittigCarlos Munoz-ZuluagaCarol NierodaVadim GushchinTeresa Diaz-Montes

Published in: Annals of surgical oncology (2021)

Age and feasibility of complete cytoreduction should be considered when treatment methods are selected for elderly patients. A carefully selected elderly population can benefit significantly from aggressive treatment methods.

Keyphrases

middle aged
squamous cell carcinoma
type diabetes
metabolic syndrome
adipose tissue
weight loss
locally advanced
replacement therapy
atrial fibrillation
smoking cessation